Since two groundbreaking treatments were approved in late 2023, only a handful of patients have been able to access the ...
Life-changing gene therapies for hemophilia have become available, yet many patients and providers have not yet rushed to try ...
Swiss drugmaker Novartis said on Monday its gene therapy helped improve motor function in children with a rare muscle ...
Benefiting from technological and conceptual groundwork and positive early data, gene therapies are advancing in the clinic ...